SOURCE: PHT Corporation

January 17, 2008 09:00 ET

PHT Convenes Pharmaceutical Industry Innovators at Fifth Annual U.S. User Group Meeting

ePRO Industry Leader Hosts Largest-Ever Gathering to Discuss Validation, Adaptive Trials, Site Perspective

BOSTON, MA--(Marketwire - January 17, 2008) - PHT Corporation, the market-leading provider of electronic patient reported outcome (ePRO) solutions used in more than 330 clinical trials worldwide, recently held its fifth annual User Group Meeting in Orlando. At the exclusive event, available only to PHT customers and partners, some of the most pioneering minds in clinical research management assembled to discuss critical topics facing the ePRO and biopharmaceutical industries, such as validation, adaptive trials and the site perspective.

The meeting was attended by 24 sponsors representing some of the largest names in the biopharmaceutical and medical device world, including GlaxoSmithKline, Merck & Co., Inc., Asthmatx Inc., Alba Therapeutics Inc., Concentrics Research, DURECT Corporation, Jazz Pharmaceuticals, Inc., and Sucampo Pharmaceuticals, Inc. Omnicomm Systems, Inc., PharmaVigilant, eResearchTechnology, Inc. and DATATRAK International were among PHT partners who co-sponsored, exhibited and presented at the meeting.

"I have a great deal of experience in the ePRO industry, and I'm surprised at how much I learned at the conference," one study sponsor reported. "During the presentations and discussions with PHT executives and other participants I obtained important information that will make our own trial safer and more efficient."

Lively lectures and interactive breakout sessions covered topics including:

--  Best Practices from PHT and customers
--  Effective eDiary designs
--  ePRO instrument development and validation
--  Defining types of eClinical data integrations
--  Customer case studies
--  Updates on FDA guidelines and PHT's recommendations
--  Adaptive sample sizing for phase II and III clinical trials
--  Global ePRO implementation
    

Another sponsor participant said, "It was very valuable to hear about the experiences other users have using the PHT device and incorporating its data. You can only get that level of information and insight from this meeting."

PHT's entire executive team attended to present talks and meet with users.

Phil Lee, PHT President and CEO, said, "We were excited about the heavy attendance and the discussion at this year's meeting. PHT is committed to learning from customers and partners how we can improve our ePRO services. Once again, our annual User Group Meeting gave us an excellent understanding of how to continue advancing ePRO technology to help our customers conduct safe, efficient scientific trials."

About PHT Corporation

PHT is the market-leading provider of electronic patient reported outcome (ePRO) solutions used in more than 330 clinical trials around the world. The company's proven LogPad® and StudyPad® Systems deliver the voice of the patient -- directly and without distortion -- with reliable and timely self-reported data. Patient experiences captured firsthand by PHT's ePRO Product Suite have been used successfully in at least eight NDA submissions, with five known approvals, to date. To learn more about how study sponsors worldwide are using ePRO to improve data quality, conduct smaller trials, and manage patient safety, enrollment and compliance in real time, visit www.phtcorp.com.

PHT, LogPad and StudyPad are among the registered trademarks and trademarks of PHT Corporation.

Contact Information